|
CYDY CytoDyn Inc 1175680 |
| Income Statement |
|
Net Income
|
2026-05-31
|
$-42,699,000.00 |
| Balance Sheet |
|
Current Assets
|
$13,878,000.00 |
|
Assets
|
$13,973,000.00 |
|
Current Liabilities
|
$53,727,000.00 |
|
Liabilities
|
$123,691,000.00 |
|
Equity
|
$-109,718,000.00 |
|
Shares Out
|
1373517000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-17,252,000.00 |
| Market Analysis |
Market Cap
|
$288,438,570.00 |
|
Price
|
$0.21 |
|
PB
|
5.75 |
|
EPS
|
-0.03 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:32 |
|
| Jan |
Feb |
Mar |
|
|
2026-01-09 |
-0.02 |
|
|
|
| Apr |
May |
Jun |
|
|
2026-04-08 |
0.00 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-10 |
0.00 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CYDY documents filed with the SEC.
CYDY Filings
Clear
